GB2530110A — Packaging
Assigned to Multi Packaging Solutions UK Ltd · Expires 2016-03-16 · 10y expired
What this patent protects
A package 106 includes a container 2 having an open end and a closed end, and a slider (54, fig. 5B) slidably mounted within the container. A releasable locking feature is provided at a side of the package, which comprises a pair of locking edges 104, one associated with a sidewa…
USPTO Abstract
A package 106 includes a container 2 having an open end and a closed end, and a slider (54, fig. 5B) slidably mounted within the container. A releasable locking feature is provided at a side of the package, which comprises a pair of locking edges 104, one associated with a sidewall of each of the slider and container respectively, and a release area 18 for releasing a locking abutment between the locking edges. The release area is provided in the sidewall of the container having the locking edge, and the locking edge comprises two or more plies of a material used to provide the slider. The locking edges cooperate to prevent movement of the slider out of the open end of the container until a user manually applies pressure to the release area to deflect the locking edge of the slider out of abutment with the locking edge of the container to permit the slider to slide past the locking edge of the container. The package may comprise a blister pack (94, fig. 4D), preferably mounted on a carrier (56), a panel of which is connected to the slider.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.